Wild-type smad3 gene enhances the osteoblastic differentiation of rat bone marrow-derived mesenchymal stem cellsin vitro

Abstract

This study examined the effect of wild-type Smad3 gene on the osteoblastic differentiation of rat bone marrow-derived mesenchymal stem cellsin vitro. Bone marrow-derived mesenchymal stem cells (MSCs) were stably transfected with the complexes of pcDNA3. 0-Myc-Smad3 or pcDNA3. 0-Myc-Smad3ΔC and Lipofectamine reagent. Immunofluorescence staining was performed to evaluate the c-Myc signal in MSCs. The cell proliferation was detected by MTT method. To clarify the osteoblastic characteristics in stably transfected MSCs, alkaline phosphatase (ALP) mRNA and core binding factor α1 (Cbfa1) mRNA were investigated by RT-PCR, and ALP activity and mineralization were examined by p-nitrophenolphosphate method and alizarin red staining respectively. PD98059, a specific inhibitor of the ERK signaling pathway, was used to determine the role of ERK in Smad3-MSCs osteoblastic differentiation. c-Myc signal was detected in Smad3-MSCs and Smad3 ΔC-MSCs. The proliferation of Smad3-MSCs was slower than that of Smad3 ΔC-MSCs or V-MSCs. The relative levels of ALP mRNA and Cbfal mRNA in Smad3-MSCs, as well as ALP activity and mineralization, were markedly higher than those in Smad3 ΔC-MSCs or V-MSCs. Although ALP activity and mineralization were slightly lower in Smad3-MSCs treated with PD98059 than in those without PD98059 treatment, no significant difference was found between them (P>0.05). It is concluded that the wild-type Smad3 gene, which is a crucial component promoting bone formation, can inhibit the proliferation of MSCs and enhance the osteoblastic differentiation of uncommitted MSCs and the maturation of committed MSCs independent of the ERK signaling pathway.

Keywords

Smad3 / bone marrow / stem cells / cell differentiation / osteogenesis

References

[1] DeansR J, MoseleyA B. Mesenchymal stem cells: Biology and potential clinical uses. Exp Hematol, 2000, 28: 875-875

[2] KimM K, NiyibiziC. Interaction of TGFβ₁ and rh-BMP2 on human bone marrow stromal cells cultured in collagen gel matrix. Yonsei Med J, 2001, 42: 338-338

[3] YangX, ChenL, XuX, et al. . TGF-beta/Smad3 signals repress chondrocyte hypetrophic differentiation and are required for maintaining articular cartilage. J Cell Biol, 2001, 153: 35-35

[4] BortonA J, FrederickJ P, DattoM B, et al. . The loss of Smad3 results in a lower rate of bone formation and osteopenia through dysregulation of osteoblast differentiation and apoptosis. J Bone Miner Res, 2001, 16: 1754-1754

[5] NagarajanR P, LiuJ, ChenY. Smad3 inhibits transforming growth factor-β and activin signaling by competing with Smad4 for FAST-2 binding. J Biol Chem, 1999, 274: 31229-31229

[6] WangY T, ZhengQ X, GuoX D, et al. . Optimal isolation and identification of rat autogeneous bone marrow derived mesenchymal stem cells. J Huazhong Univ Sci Tech (Health Sci) (Chin), 2003, 32: 526-526

[7] HillP A, TumberA, MeikleM C. Multiple extracellular signals promote osteoblast survival and apoptosis. Endocrinology, 1997, 138: 3849-3849

[8] ShuiC, SpelsbergT C, RiggsB L, et al. . Changes in runx2/cbfal expression and activity during osteoblastic differentiation of human bone marrow stromal cells. J Bone Miner Res, 2003, 18: 213-213

[9] ZhangH, AhmadM, GronowiczG. Effects of transforming growth factor-beta 1 (TGFβ₁) on in vitro mineralization of human osteoblasts on implant materials. Biomaterials, 2003, 24: 2013-2013

[10] JaiswalR K, JaiswalN, BruderS P, et al. . Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem, 2000, 275: 9645-9645

[11] BlanchetteF, RivardN, RuddP, et al. . Cross-talk between the p42/p44 MAP kinase and smad pathways in transforming growth factorβ₁-induced furin gene transactivation. J Biol Chem, 2001, 276: 33986-33986

[12] SahaD, DattaP K, BeauchampR D. Oncogenic ras represses transforming growth factor-β/Smad signaling by degrading tumor suppressor Smad4. J Biol Chem, 2001, 276: 29531-29531

[13] WatanabeH, de CaesteckerM P, YamadaY. Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factorβ-induced aggrecan gene expression in chondrogenic ATDC5 cells. J Biol Chem, 2001, 276: 14466-14466

[14] HeldinC H, MiyazonoK, ten DijkeP. TGFβ signaling from cell membrane to nucleus through SMAD proteins. Nature, 1997, 390: 465-465

[15] ZhangY, DerynckR. Regulation of Smad signalling by protein associations and signaling crosstalk. Trends Cell Biol, 1999, 9: 274-274

[16] MassagueJ, WottonD. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J, 2000, 19: 1745-1745

[17] EngelM E, McDonnellM A, LawB K, et al. . Interdependent SMAD and JNK signaling in transforming growth factorβ-mediated transcription. J Biol Chem, 1999, 274: 37413-37413